CaPTC

Using research as a tool, we are committed to improving the well-being of Black men living with prostate cancer.

[CaPTC @CaPTC7]

Great shots from #SoAPCA25.

We bring you highlights from one of our biggest events in 2025.

#ViralMMSVideo #viral2026 #cancerresearch

[CaPTC @CaPTC7]

Hi🖐️😊

Welcome to the month in which we celebrate Prostate Cancer Awareness.

Remember, early detection can save your life or that of your loved one.

Catch it early! That's the best bet.

#ConsortiumScience #GlobalHealthResearch #ProstateCancerResearch #ConsortiumScience

[CaPTC @CaPTC7]

for this outstanding achievement.

This is what progress looks like-building capacity, strengthening partnerships, & shaping the future of inclusive cancer research.

#iCCaRE #GlobalOncology #CancerResearch #ClinicalTrials #HealthEquity #Nigeria #AfricanResearch #GlobalHealth

[CaPTC @CaPTC7]

🌍 CaPTC Celebrates Professor Popoola: A Landmark Achievement in Global Cancer Research 🏆

The #CaPTC proudly celebrates Professor Popoola on the official registration of the **iCCaRE Nigeria Clinical Trial** on *https://t.co/pr8FcgFSPm* (NCT07598032)—a major step for forward

[CaPTC @CaPTC7]

cancer research in Nigeria & across Africa.

This milestone reflects exceptional scientific leadership, collaboration, & a shared commitment to advancing equitable, globally impactful oncology research.

👏🏾 Congratulations to Professor Popoola and the entire iCCaRE Nigeria team

[CaPTC @CaPTC7]

hasn't grown beyond the prostate.

Stage 2C - Stage 2C prostate cancers are grade group 3 or 4 and the PSA level is low or intermediate. This stage includes any size cancer, as long as the cancer hasn't grown beyond the prostate.

Check with your Doctor today. Know your status!

[CaPTC @CaPTC7]

#Prostate Cancer grows in stages & it's good to catch it early.

What you need to know about Stage 2 Prostate #Cancer 👇

Stage 2A - Stage 2A prostate cancers are grade group 1. At this stage, the cancer may be a small cancer that only affects one side of the prostate but has

[CaPTC @CaPTC7]

an intermediate PSA level. Or it can be a larger cancer that affects both sides of the prostate but has a low PSA level.

Stage 2B - Stage 2B prostate cancers are grade group 2 and the PSA level is low or intermediate. This stage includes any size cancer, as long as the cancer

[CaPTC @CaPTC7]

Addressing these gaps starts with awareness and action. Everyone deserves the opportunity for early detection and quality care.

#HealthDisparities #HealthEquity #ProstateCancerAwareness #CaPTC

[CaPTC @CaPTC7]

Stage 1 treatment usually involves active surveillance because the cancer is small and growing slowly. Still, some people might choose to have treatment if they are younger and willing to accept some side effects in order to cure the cancer.

-Mayo Clinic

[CaPTC @CaPTC7]

Bringing you more news covered in the most recent edition of our Newsletter.

Read on CaPTC infrastructure, BRCA breakthrough & something on our site at FMC, Abuja.

#ResearchInAfrica #AbujaTwitterCommunity #GlobalHealth #SciencelnAction #PublicHealthImpact #BuildingTheFuture

[CaPTC @CaPTC7]

#ResearchInAfrica #GlobalHealth #SciencelnAction #PublicHealthImpact #BuildingTheFuture

[CaPTC @CaPTC7]

Celebrating Dr. Tchokote from Cameroon who won the Best Poster Award at the just concluded iCCaRE Symposium for the topic "Psychological impact of prostate cancer on the quality of life of patients in Cameroon."

inset @EKaninjing receiving the award on her behalf.

[NICRAT @NicratGov]

𝗡𝗜𝗖𝗥𝗔𝗧 ��𝗮𝗴𝘀 𝗔𝘄𝗮𝗿𝗱 𝗙𝗼𝗿 𝗘𝘅𝗰𝗲𝗹𝗹𝗲𝗻𝗰𝗲 𝗶𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

The National Institute for Cancer Research and Treatment (NICRAT) has been conferred with an award for Excellence in Cancer Research by the Capital Health Awards Academy.

The award was in recognition of the efforts of the Institute in transforming cancer research in Nigeria.

Speaking during a brief ceremony at the NICRAT Headquarters in Abuja, the Convener/Founder of Capital Health Awards Academy, Salomey Ejefero, stressed that her organisation has carefully watched the activities of NICRAT since inception, especially, its efforts in building a globally accepted research culture and also expanding the cancer research landscape in Nigeria.

According to her, Capital Health Awards Academy decided to recognize the institute after it passed through the scrutiny of several stakeholders who remained unanimous that NICRAT is putting the right structures and building the needed capacity to ensure that Nigeria takes its rightful place in terms of cancer research globally.

She commended the NICRAT DG and his team for standing tall despite all challenges and making sure that the Institute is focused in delivering its key mandate leading to unprecedented improvement in cancer awareness, treatment and research.

“In recognition of its outstanding contributions to building a cohesive, scientifically rigorous, and collaborative national cancer research ecosystem, NICRAT is hereby honored for its excellence and visionary leadership.

“The purpose is to honor this institution and to encourage them to continue to affect the oncology space with the same vigor that they started so that by the time the pioneer DG is done, there will be something that the whole nation will rest on. Let this award push you to do more things than you have done before.”

While presenting the award, the former National Coordinator of National Cancer Control Programme (NCCP), at the Federal Ministry of Health and Social Welfare, Dr. Ramatu Hassan, noted that Nigeria has made remarkable progress in the fight against cancer.

She applauded the NICRAT Director General, Prof. Usman Malami Aliyu, for working hard to ensure that Nigeria is doing well in cancer prevention, treatment and research.

In his remarks after receiving the award, the DG NICRAT, Prof. Malami, appreciated the Capital Health Awards Academy team, noting that all the successes achieved by the Institute since inception was due to the support and encouragement from the President Bola Ahmed Tinubu-led federal government, the Minister of Health and Social Welfare, Prof. Muhammad Ali-Pate and the Minister of State for Health and Social Welfare, Dr. Iziaq Adekunle Salako and other well-meaning Nigerians working in the cancer space.

He assured that NICRAT will continue to work hard to ensure that Nigeria gets it right and also dominate the African continent in terms of cancer research.

#NICRAT #NCCP #AwardAcademy #FMoHSW #SAGAR

[NCCP Nigeria @nccpnigeria]

The Federal Ministry of Health and Social Welfare hit a massive milestone with the inauguration of the National Cancer Control Plan, a five year strategic plan to reduce the burden of cancer in Nigeria.

The launch which held physically and virtually had as many as 142 attendees

[iCCaRE Consortium @iCCaREMedia]

🌍 Transforming Community Health with Precision

🎬 Check out a sneak peek of our upcoming CoLLaB commercial, premiering in full at the iCCaRE Prostate Cancer Scientific Symposium on April 14th!

https://t.co/TZJlLk9FmB

• Precision Public Health: Using community engagement, data, and technology with geographic precision to prevent disease, predict risk, and design tailored interventions that improve health outcomes and reduce disparities.

• Precision Community Health: Delivering health interventions tailored to each community, taking into account social, cultural, behavioral, and environmental context.

In CoLLab, service meets science, and care becomes the community.

#iCCaRE #CommunityHealth #PrecisionPublicHealth #HealthEquity #CancerAdvocacy #CoLLaB

[iCCaRE Consortium @iCCaREMedia]

🎥 Clinical Trials Demystified Episode 1, hosted by Dr. Bolajoko is on Youtube

Just in case you missed the live premiere, you can watch the full episode here:
▶️ https://t.co/97eQ5g24lZ

We’re breaking down the basics, what clinical trials are, how they work, and why they matter for advancing care and saving lives.

#ClinicalTrials #HealthEquity #CancerResearch #iCCaRE #ClinicalTrialsDemystified

[iCCaRE Consortium @iCCaREMedia]

Curious about how clinical trials really work? 🤔

Just in case you missed the live premiere, watch the full episode here:

▶️ https://t.co/u6aBHSRH3m

🎥 Episode 2 of Clinical Trials Demystified, hosted by Dr. Bolajoko, features an in-depth conversation with Dr. Floyd Willis about the process, purpose, and impact of clinical trials.

#ClinicalTrials #HealthEquity #CancerResearch #iCCaRE #ClinicalTrialsDemystified

[CaPTC @CaPTC7]

#AmbiancePâques #RechercheCancer #SensibilisationAuCancer

[CaPTC @CaPTC7]

Joyeuses Pâques à tous nos hommes et à leurs familles. Nous espérons que vous passez de bonnes fêtes et que vous vous portez bien. Au CaPTC, nous restons fidèles à notre vision à long terme: créer un système qui allège le fardeau du cancer de la prostate pour la population noire.

[CaPTC @CaPTC7]

Nous continuons de déployer des stratégies novatrices pour atteindre cet objectif. Nous collaborons également avec certains des meilleurs experts mondiaux en sciences et en recherche, qui mettent leurs talents et leur expérience à contribution.